Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ipilimumab-induced orbital inflammation resembling Graves disease with subsequent development of systemic hyperthyroidism from CTLA-4 receptor suppression.

Literature DB >> 24398505

Ipilimumab-induced orbital inflammation resembling Graves disease with subsequent development of systemic hyperthyroidism from CTLA-4 receptor suppression.

Gary E Borodic, David Hinkle.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2014 PMID： 24398505 DOI： 10.1097/IOP.0000000000000033

Source DB: PubMed Journal: Ophthalmic Plast Reconstr Surg ISSN： 0740-9303 Impact factor: 1.746

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

Review 1. Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.

Authors: Meng H Tan; Ravi Iyengar; Kara Mizokami-Stout; Sarah Yentz; Mark P MacEachern; Li Yan Shen; Bruce Redman; Roma Gianchandani
Journal: Clin Diabetes Endocrinol Date: 2019-01-22

2. Severe Inflammatory Ophthalmopathy in a Euthyroid Patient during Nivolumab Treatment.

Authors: Pauline Campredon; Philippe Imbert; Céline Mouly; Solange Grunenwald; Julien Mazières; Philippe Caron
Journal: Eur Thyroid J Date: 2018-01-04

3. Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study.

Authors: Norio Okada; Shintaro Iwama; Takayuki Okuji; Tomoko Kobayashi; Yoshinori Yasuda; Eri Wada; Takeshi Onoue; Motomitsu Goto; Mariko Sugiyama; Taku Tsunekawa; Hiroshi Takagi; Daisuke Hagiwara; Yoshihiro Ito; Hidetaka Suga; Ryoichi Banno; Tetsunari Hase; Masahiro Morise; Mitsuro Kanda; Kenji Yokota; Naozumi Hashimoto; Masahiko Ando; Yasushi Fujimoto; Masato Nagino; Yasuhiro Kodera; Mitsuhiro Fujishiro; Hideharu Hibi; Michihiko Sone; Hitoshi Kiyoi; Momokazu Gotoh; Yuichi Ando; Masashi Akiyama; Yoshinori Hasegawa; Hiroshi Arima
Journal: Br J Cancer Date: 2020-02-03 Impact factor: 7.640

Ipilimumab-induced orbital inflammation resembling Graves disease with subsequent development of systemic hyperthyroidism from CTLA-4 receptor suppression.

Review 1. Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.

2. Severe Inflammatory Ophthalmopathy in a Euthyroid Patient during Nivolumab Treatment.

3. Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study.

Review 4. Immunotherapy-induced endocrinopathies: assessment, management and monitoring.

Review 5. Endocrine toxicity of cancer immunotherapy: clinical challenges.

Review 6. Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis.

7. Sneaky side effects and ineffectiveness of an immunotherapy with ipilimumab in a case of metastatic melanoma.

8. Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma.